Wall Street is positive on Hologic, Inc. (HOLX). On average, analysts give HOLX a Buy rating. The average price target is $81.363, which means analysts expect the stock to gain by 18.59% over the next twelve months.
That average ranking earns HOLX an Analyst Rating of 30, which is better than 30% of stocks based on data compiled by InvestorsObserver.
Wall Street analysts are rating HOLX a Buy today. Find out what this means to you and get the rest of the rankings on HOLX!
Why are Analyst Ratings Important?
Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.
InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.
What's Happening With Hologic, Inc. Stock Today?
Hologic, Inc. (HOLX) stock has fallen -0.88% while the S&P 500 is higher by 0.37% as of 3:15 PM on Friday, Dec 8. HOLX is down -$0.61 from the previous closing price of $69.22 on volume of 866,119 shares. Over the past year the S&P 500 is up 16.12% while HOLX is down -8.28%. HOLX earned $1.83 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 37.38.
Click Here to get the full Stock Report for Hologic, Inc. stock.